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A B S T R A C T
 
Objective: Compare the anti-T. gondii IgG titer between HIV-1 infected and non HIV-1 infected 
pregnant women and report three cases of congenital toxoplasmosis resulting from 
reactivation of infection during pregnancy of HIV-1 infected women. 
Methods: This study was conducted among 2,270 pregnant women with chronic Toxoplasma 
gondii infection (absence of IgM and presence of IgG), including 82 HIV-1 infected and 2,188 
non-infected women. 
Results: The average anti-T. gondii IgG titer was 127 for the 2,188 non-HIV-1 infected women, 
and 227 for the 82 HIV-1-infected women (p = 0,007). These results suggested that higher 
anti-T. gondii IgG titers in HIV-1-infected pregnant women may not be indicative of an 
elevated risk for fetal infection. In this study three cases of congenital toxoplasmosis 
that resulted from infection reactivation during pregnancy of HIV-1-infected women 
were manifested by fetal death, symptomatic infection, and infant without symptoms, 
respectively. In two of these women, a ten-fold increase in IgG levels above used cutoff 
was observed (2,320 UI/mL and 3,613 UI/mL, respectively). In the third pregnant women 
anti-T. gondii IgG titers during pregnancy did not rise despite the occurrence of congenital 
toxoplasmosis (204; 198; 172 UI/mL). 
Conclusions: Congenital toxoplasmosis resulting reactivation of infection during pregnancy 
in the studied group leads us to believe that it is a public health problem, especially in 
our population, in which seroprevalence of T. gondii infections is high. These findings 
also suggest that special attention is necessary during pregnancy, because the serologic 
diagnosis may not be indicative of toxoplasmosis reactivation. 
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Introduction
Toxoplasmosis is an infection that is typically manifested 
as a non-specific or asymptomatic presentation in 
immunocompetent individuals.  The infection can 
remain latent after the acute phase and is characterized 
by the presence of the parasite within tissue cysts.1 In 
cases where the immune system is not able to control 
parasite replication, clinical disease may ensue and cause 
complications, especially visual and neurological.2 The 
most susceptible individuals to the more serious forms 
of the disease are fetuses and newborns of pregnant 
women who become infected during pregnancy, and 
immunosuppressed patients.3
The fetal transmission of toxoplasmosis occurs predomi-
nantly when the mother is infected during pregnancy, a 
situation where the diagnosis is usually made through 
serological tests. However, congenital toxoplasmosis may 
also be associated with reactivation of a chronic maternal 
infection, especially in HIV-1-infected and immunosup-
pressed women,4-11 or with reinfection by a different strain 
of Toxoplasma gondii.12,13
The diagnosis of reactivated T. gondii infection during 
pregnancy has been the subject of much controversy. Some 
studies have tried to correlate higher anti-T. gondii IgG 
serum titers with reactivation of the infection irrespective 
of the levels of CD4+ T-lymphocytes.5,14 However, recent 
research in southern Brazil has shown higher anti-T. gondii 
IgG levels in HIV-1-infected than in non-HIV-1-infected 
pregnant women. These results suggest that the increase 
in antibody titers (IgG) could be the result of polyclonal 
activation of B-lymphocytes, which are not parasite-
specific.15 Therefore, the interpretation of such IgG titers 
is not necessarily indicative of a reactivated infection, as 
proposed by other authors.16-18
The objectives of this study were: 1) to compare anti-T.
gondii IgG class antibody levels among HIV-1-infected and 
uninfected pregnant women previously exposed to the 
parasite; 2) to correlate anti-T. gondii IgG class antibody 
levels with the levels of CD4+ T-lymphocytes and HIV 
plasma viral load in HIV-1-infected pregnant women.
Patients and methods
This was a retrospective study conducted at the Hospital 
Universitário Antônio Pedro at Universidade Federal 
Fluminense (HUAP-UFF), Niterói, Rio de Janeiro, Brazil, from 
June 2002 to June 2009. 
The entire pregnant population of this study received 
medical assistance at the public health system.
The inclusion criteria for this study were: 1) availability of 
serological tests for toxoplasmosis during the prenatal period 
or upon admission of the patient in labor to HUAP-UFF from 
June 2002 to June 2009; 2) presence of a serological profile 
compatible with chronic toxoplasmosis infection, defined 
as the presence of serum anti-T. gondii IgG class antibodies and 
the absence of anti-T. gondii IgM antibodies.
We compared anti-T. gondii IgG levels among HIV-1-infected 
and uninfected pregnant women.
The serological results for toxoplasmosis in non-HIV-
1-infected pregnant women were taken from the patient 
record archives of the immunology sector of the HUAP-UFF 
Laboratory. For the HIV-1-infected pregnant women pertinent 
information (age, delivery date, confirmation of HIV diagnosis, 
anti-T.gondii IgG titers, CD4+ T-lymphocyte count and HIV 
plasma viral load) were taken from medical records at the 
Infectious and Parasitic Disease Service. 
Among the HIV-1-infected pregnant women chronically 
infected with T. gondii, those who had their serology, CD4+ 
count and HIV-1 viral load determination collected at the same 
day were analyzed separately. 
Children born to HIV-1-infected mothers received medical 
assistance at the Pediatric AIDS Clinic of the HUAP-UFF. As 
a routine service, serology for toxoplasmosis was performed 
during pregnancy or during the child’s first consultation. 
Asymptomatic children who had anti-T. gondii IgG titer lower 
than the mother’s were  examined every two months until it 
turned negative. Symptomatic children and/or children with 
positive anti-T. gondii IgM and/or toxoplasma IgG titer equal 
to or higher than the mother’s, underwent transfontanellar 
ultrasound and a fundoscopic examination to confirm the 
diagnosis of congenital toxoplasmosis. 
Serological diagnosis of toxoplasmosis in the pregnant 
women and children were performed using IgG and IgM 
class antibody determination. The laboratory technique 
employed for these tests was the enzyme linked fluorescent 
assay (ELFA) using the VIDAS System (bioMérieux – Lyon, 
France), with the following reference values for positive 
results: IgM > 0.65 and IgG > 8 UI/mL. Pregnant women were 
classified into three groups according to their serological 
profiles: 1) Susceptible: absence of anti-T. gondii IgG 
and IgM antibodies; 2) Acute infection: presence of 
anti-T. gondii IgM and IgG antibodies; 3) Chronic infection: 
presence of anti-T. gondii IgG antibodies and absence 
of anti-T. gondii IgM antibodies. 
The database for the analysis was prepared using the 
Statistical Package for Social Sciences (SPSS) version 18.0 
for Windows©. We used the Chi-square test (χ²) to compare 
the prevalence of chronic T. gondii infection among HIV-1 
infected and uninfected pregnant women, as well as for 
comparing age groups and analyzing the influence of age 
on the prevalence of immunity in the two groups. We used 
the Spearman correlation coefficient to assess associa-
tions between the numerical variables. For the compari-
son between continuous variables in the two groups were 
used Student’s t-test. A p-value less than 0.05 was consid-
ered statistically significant.
This study was approved by the Research Ethics 
Committee  at  the  HUAP-UFF,  under  the  number 
0268.0.258.000-09. 
Results
From June 2002 to June 2009, we evaluated 2,270 pregnant 
women, among whom 2,188 were not infected with HIV-1 
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and 82 had a confirmed diagnosis of HIV-1 infection. 
Fig. 1 describes the study population and the respective 
serological profile.
Of the 49 fetuses born to HIV-1-infected mothers with 
chronic T. gondii infection, three children were diagnosed 
with congenital toxoplasmosis. Previously published data4 
suggest that such unfavorable outcome resulted from 
reactivation of maternal T. gondii infection during pregnancy. 
The first pregnant woman had low titers of anti-T. gondii 
IgG antibody and lacked IgM antibody. At the 21st week of 
pregnancy, the IgG titers were 2,320 IU/mL (ELFA/VIDAS) 
with high IgG antibody avidity. At the 28th week, fetal death 
was confirmed. A histological study of the placenta and 
embryo confirmed the diagnosis of congenital toxoplasmosis.
In the second case, IgM antibodies were not detected and 
increasing IgG titers during pregnancy (364 IU/mL in the 
20th week of pregnancy and 3,613 IU/mL in the 36th week) 
with high-avidity IgG antibodies were observed. The 
child was born with anti-T. gondii IgM antibodies and severe 
clinical manifestations of congenital toxoplasmosis and was 
treated during the first year of life. 
In the third patient, at the 33rd week of pregnancy 
anti-T. gondii antibody test was inconclusive for the IgM 
class and positive for the IgG class (204 IU/mL). At the 36th 
week of pregnancy, uveitis caused by toxoplasmosis was 
diagnosed and specific treatment begun. On this occasion, 
T. gondii serology showed high avidity anti-T. gondii IgG 
antibody titers at 198 IU/mL in the absence of IgM (ELFA). 
The child was delivered at the 38th week and IgM and IgG 
(titer: 172 IU/mL — ELFA) anti-T. gondii antibodies were 
detected. During follow-up visits, the child was diagnosed 
with HIV-1 infection. Anti-retroviral treatment and 
toxoplasmosis treatments were initiated.
Discussion
This study demonstrates a similar prevalence of T. gondii 
infection in HIV-1-infected pregnant women when compared 
to uninfected women. The results are consistent with other 
studies that have demonstrated similar serological prevalence 
between the two groups, as well as in the general popula-
tion.11,19-22
Characteristics 
 
Non-HIV-1-infected 
pregnant women 
(n = 2,188)
HIV-1-infected  
pregnant women 
(n = 82)
p-value  
 
Median age in years (IQR) 25 (20-30) 25.2 (21.4-30.7) 0.768
Patients immune to toxoplasmosis (%) 1271 (58.1%) 49 (59.8%) 0.402
Median anti-toxoplasma IgG (IQR) 127 (60.5-242) 227 (107-684) 0.007
Age group 
 10-19 years 444 (20.3%) 13 (15.9%) 0.465
 20-30 years 1208 (55.2%) 48 (58.5%)
 > 30 years 536 (24.5%) 21 (25.6%)
HIV-1, human immunodeficiency virus; IQR, interquartile range.
Table 1 - Demographic and serological characteristics and distribution according to age group of HIV-1-infected and 
uninfected pregnant women treated at HUAP-UFF from 2002 to 2009
Fig. 1 - Description of the study realized in a pregnant 
population and its serological profile – Niterói, Rio de 
Janeiro, 2002-2009. HIV, human immunodeficiency virus.
Table 1 shows the demographic and serological 
characteristics of the two groups of pregnant women studied, 
as well as their distribution according to age group.
Among the 49 HIV-1-infected patients with a chronic 
T. gondii infection, 38 had their serologies, CD4+ T-lymphocyte 
counts and HIV-1 plasma viral load collected on the same 
day. Within this group, the median anti-T. gondii IgG titer was 
247 IU/mL (IQR: 116.8-807.8), the median CD4+ T-lymphocyte 
count was 330 cells/mm3 (IQR: 228-538) and the median plasma 
viral load of HIV-1 was 3,066 copies/mL (IQR: 80-13,500). Among 
these 38 pregnant women, anti-T. gondii IgG titers were neither 
significantly different among those with CD4+ T-lymphocyte 
counts below or above 100 cells/mm3 nor above or below 
300 IU/mL (p = 0.0934). The IgG values considered were not 
absolute but a classification from a cut-off point (below or 
above 300 IU/mL). There was no significant difference of 
anti-T. gondii IgG titers of HIV-1-infected pregnant women 
between those with undetectable (below 80 copies/mL) and 
detectable HIV-1 viral load (p = 0.477).
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Persistence of high seroprevalence could reflect greater 
circulation of the parasite in our environment, leaving the 
pregnant women, already exposed, susceptible to reinfection, 
either by new strains or reactivation of the chronic infection.
There was no difference in the seroprevalence of 
toxoplasmosis among HIV-1-infected and uninfected 
pregnant women adjusted for age. Thus, the susceptibility 
to a primary infection was equal for both groups, which 
may be explained by the same regional origin of the groups 
of pregnant women.
In our study anti-T. gondii IgG titers were higher in the 
group of HIV-1-infected than uninfected pregnant women. 
This finding is similar to other reports where elevated 
anti-T.gondii IgG serological titers in HIV-1-infected patients 
were seen.15,23 However, other studies have not found any 
difference in anti-T. gondii IgG antibody titers.21,24,25 Several 
factors may explain these discrepancies, such as difference in 
age and/or study population. Among HIV-1-infected patients, 
hypergammaglobulinemia is common and seems to be caused 
by the activation of polyclonal B-cells. This may explain the 
higher anti-T. gondii IgG titers among HIV-1-infected patients 
without taking into account the duration of the infection or 
its reactivation state.16,18
This study found three HIV-1-infected pregnant 
women who were chronically infected with T. gondii 
and who transmitted toxoplasmosis to their fetuses 
during pregnancy. When we analyzed their respective 
serological profiles, these patients did not have anti-T. gondii 
IgM class antibodies during pregnancy, but only IgG antibodies. 
One of the pregnant women had a significant increase in 
anti-T. gondii IgG antibody titers during the course of her 
pregnancy. This finding may be related to reactivation of a 
latent infection and subsequent vertical transmission of the 
infection. Therefore, although the anti-T. gondii IgG antibody 
titers were typically elevated in HIV-1-infected pregnant 
women, monitoring these titers during pregnancy may be 
useful for the early detection of reactivation. However, the 
serological profiles in these pregnant women were different, 
and there were no large variations in the anti-T. gondii IgG 
class antibody titers. In one pregnant woman, reactivation 
of ocular lesions was caused by toxoplasmosis. This finding 
is consistent with reports of vertical transmission of the 
infection as a result of ocular toxoplasmosis reactivation.26,27 
The reactivation of ocular lesions caused by toxoplasmosis 
in the absence of IgM antibodies and the presence of 
anti-T. gondii IgG antibodies are suggestive of infection 
reactivation as opposed to reinfection with another strain.28 
Three cases of congenital toxoplasmosis were identified. In the 
first case, fetal death occurred in the 28th week of pregnancy. 
Fetal autopsy showed hepatosplenomegaly, anasarca, 
pericarditis and myocarditis. In the second case, the infant 
showed chorioretinal scars, intracranial calcification on brain 
CT scan and neurodevelopment delay; and in the last case 
the newborn was HIV-infected but congenital toxoplasmosis 
was asymptomatic. These cases have already been published.4
Some authors have documented that HIV-1-infected 
pregnant women who acquire toxoplasmosis during pregnancy 
(in contrast to immunocompetent women) do not have 
anti-T. gondii IgM antibodies and have IgG titers that remain 
low.15 In HIV-1 infections, hypergammaglobulinemia has been 
observed in conjunction with the selective loss of specific 
antibody production.18,29 Reduction of the immune response to 
specific antigens is associated with a reduction in the number of 
memory B-cells.18 Thus, due to their reduced humoral response 
against recently acquired antigens, in immunocompromised 
patients, the absence of IgM antibodies and low levels of 
anti-T. gondii IgG antibodies may be indicative of an acute 
infection, unlike in immunocompetent patients.16,18,29
In this study, there was no relationship between either 
the levels of CD4+ T-lymphocyte count or the magnitude 
of HIV-1 viral load and anti-T. gondii IgG titers. The interpre-
tation of these results is limited due to the small sample of 
HIV-1-infected pregnant women. Therefore, our results 
should not be generalized.
The rate of vertical transmission of toxoplasmosis in 
HIV-1-infected pregnant women previously exposed to 
T. gondii has not yet been defined. Some authors have reported 
that congenital toxoplasmosis due to the reactivation of a 
maternal infection is less frequent than usually expected.9,30 
In this study, we observed three cases of vertical transmission 
of toxoplasmosis due to reactivation of maternal infection 
in HIV-1-infected pregnant women. In our literature review, 
three additional cases of fetal infection due to reactivation of 
maternal toxoplasmosis in HIV-1-infected women were found 
in the last three years.7,31,32
Our study has some limitations. The results were based 
on cross-sectional data from HIV-positive patients with 
chronic T. gondii infection who may not represent the 
hypothetical original cohort of patients, among whom losses 
were not random. In addition, the current data are based on 
HIV-1-infected patients selected from a public hospital, who 
may not have been truly representative of the HIV-infected 
population of the municipalities of study from which they 
came. On the other hand, there is no reason to suppose 
that Toxoplasma infected individuals would be more likely 
to be seen at our hospital. These selection factors limit 
generalizability of our estimates of Toxoplasma reactivation 
infection rates in HIV-1- infected pregnant women. 
Further multicenter studies should be conducted to 
address the poorly understood issues regarding T. gondii infec-
tions in HIV-1-infected pregnant women. Such studies would 
allow for early implementation of effective preventive and 
therapeutic measures aimed at reducing the morbidity 
and mortality of this disease in the pediatric population.
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